Fractionation of AML cells into phases of the cell cycle using Hst/PY staining
| Patient . | % of total gated cells (% cytogenetically abnormal by FISH) . | ||
|---|---|---|---|
| G0 . | G1 . | S/G2 + M . | |
| 1 | 4.6 (91) | 90.6 (89) | 4.8 (90) |
| 2 | 2.8 | 93.2 | 4.0 |
| 4 | 3.3 (31) | 93.6 (29) | 3.1 (35) |
| 5 | 2.9 | 93.3 | 3.7 |
| Mean ± SD | 3.4 ± 0.8 | 92.7 ± 1.4 | 3.9 ± 0.7 |
| Lin− NBM4-150 A | 39.6 | 54.0 | 6.4 |
| Lin− NBM B | 44.6 | 48.2 | 7.2 |
| Patient . | % of total gated cells (% cytogenetically abnormal by FISH) . | ||
|---|---|---|---|
| G0 . | G1 . | S/G2 + M . | |
| 1 | 4.6 (91) | 90.6 (89) | 4.8 (90) |
| 2 | 2.8 | 93.2 | 4.0 |
| 4 | 3.3 (31) | 93.6 (29) | 3.1 (35) |
| 5 | 2.9 | 93.3 | 3.7 |
| Mean ± SD | 3.4 ± 0.8 | 92.7 ± 1.4 | 3.9 ± 0.7 |
| Lin− NBM4-150 A | 39.6 | 54.0 | 6.4 |
| Lin− NBM B | 44.6 | 48.2 | 7.2 |
Lineage-depleted normal bone marrow cells.